Skip to content
Logo.
The HBS Digital Initiative reshapes digital to create a world where technology advances and serves humanity. The DI manages this forum to highlight perspectives from the HBS student community.
Want to learn more about technology and organizations? digital.hbs.edu
Close and dismiss. Expand.
Technology and Operations Management

Technology and Operations Management

MBA Student Perspectives

  • Assignments
Search for:
  • Log In
  • Log In

    [wppb-login display="true" lostpassword_url="https://d3.harvard.edu/platform-rctom/lostpassword" redirect_url="https://d3.harvard.edu/platform-rctom/category/uncategorized/rna/"]

RNA

Reprogramming cells to fight disease: Rewriting the rules of biopharma R&D

Posted on December 7, 2015 by MLefferts

Moderna is a pioneer in the revolutionary new field of RNA therapetutics – a technology which allows the human body to help heal itself. No only are they delivering a new technology, but they're doing it in a novel way. Remember Wyeth Pharmaceuticals? They took 4-7 years to discover a new drug target and begin preclinical testing. Moderna does it in a matter of weeks.

[contact-form-7 title="newsletter-subscribe-component" html_class="di-c-input-group di-c-input-group--large"]
A project of:
At:
  • Assignments
  • Terms and Conditions / Privacy Policy
  • Community Guidelines
  • Contact Us